Syndax Pharmaceuticals (SNDX) Competitor Comparison
We are evaluating the key criteria listed to compare Syndax Pharmaceuticals (SNDX) against its competitors in the Biotechnology industry.
Market Capitalization
81 / 368Gross Profits
0 / 278Total Revenue
0 / 300EBITDA
281 / 337Free Cashflow
262 / 352Quick Ratio
80 / 357Earnings per Share
276 / 359Dividend yield
0 / 6Total Cash
81 / 358Performance 3 years
78 / 368Performance 5 years
30 / 368Performance 10 years
72 / 368Linearity 3 years
29 / 368Linearity 5 years
280 / 368Linearity 10 years
193 / 368Total Rank
271 / 368Dividend Rank
18 / 368Valuation Rank
234 / 368Piotroski Rank
24 / 368Muliplier Rank
213 / 368Muliplier Rank - SNDX ranking 213 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.